Comparison Study of the Effect of Erlotinib as a Tyrosine Kinase Inhibitor on Electrolyte Levels in Type2 Diabetic and Diabetic Nephropathy. Ibn AL-Haitham Journal For Pure and Applied Sciences, [S. l.], v. 31, n. 3, p. 63–69, 2018. DOI: 10.30526/31.3.2011. Disponível em: https://jih.uobaghdad.edu.iq/index.php/j/article/view/2011.. Acesso em: 7 may. 2024.